Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.375 USD | -1.79% | +5.43% | -30.96% |
May. 13 | Ikena Oncology, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Mar. 12 | Ikena Oncology, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-30.96% | 67.56M | |
+31.91% | 50.85B | |
+0.87% | 42.82B | |
+48.83% | 42.03B | |
-4.22% | 29.55B | |
+10.85% | 26.11B | |
-22.09% | 19.13B | |
+7.87% | 13.05B | |
+26.28% | 12.16B | |
+23.33% | 12.08B |
- Stock Market
- Equities
- IKNA Stock
- News Ikena Oncology, Inc.
- Ikena Oncology Gets FDA Fast Track Label for IK-175 Plus Nivolumab to Treat Urothelial Carcinoma